BridgeBio Oncology Therapeutics, Inc (BBOT) vs Benitec Biopharma Limited (BNTC)

BridgeBio Oncology Therapeutics, Inc and Benitec Biopharma Limited are both Biotechnology companies. BridgeBio Oncology Therapeutics, Inc and Benitec Biopharma Limited are of similar size ($336.2M and $319.9M). Across the 10 metrics below, Benitec Biopharma Limited leads on 6 and BridgeBio Oncology Therapeutics, Inc on 4.

Valuation

Metric BBOT BNTC Biotechnology median
P/E n/m n/m 7.88
P/S n/m 5,953.22 11.47
P/B 0.98 2.52 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 3,555.62 10.73
Earnings yield (69.87%) (10.25%) (28.84%)
Free cash flow yield (47.93%) (3.72%) (23.03%)

Profitability

Metric BBOT BNTC Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (252.10%) (33.21%) (57.72%)
Return on assets (96.69%) (32.28%) (49.22%)
Return on invested capital (127.66%) 0.00% 0.00%

Growth

Metric BBOT BNTC Biotechnology median
Revenue growth (TTM) — (1.32%) 5.64%
EPS growth (last fiscal year) 99.93% 6.83% —
Revenue growth, 5-year CAGR — 4.92% 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BBOT BNTC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.69 34.00 4.73
Net debt to EBITDA 2.93 3.52 0.96

Dividend

Metric BBOT BNTC Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric BBOT BNTC Biotechnology median
Market cap 319.90m 336.24m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack